Despite being one of the oldest viruses known to infect man, there's been slow progress toward a cure for the disease. But a promising clinical trial, led by Janssen researcher Heather Davis, Ph.D., is sparking hope.
Announced ahead of the International AIDS Society Conference on HIV Science in Mexico City, the new study will evaluate an investigational vaccine regimen in eight countries around the world for its ability to protect people from HIV infection.
As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.
Ever wonder what's in the mouthwash, lotion or shampoo you use? Kurt Reynertson knows everything there is to know about the ingredients in the company's consumer products—and the measures Johnson & Johnson takes to keep you safe.